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Multiplex PCR with specific primers for E2/E6 genes was used to assess the viral integration
status of HPV-16 in women with low and high grade squamous intraepithelial lesions (LSIL
and HSIL, respectively) in comparison to cervical cancer patients. Women with confirmed
HPV-16 infection were examined: 30 with LSIL, 12 with HSIL and 23 with cervical cancer.
The PCR products were separated electrophoretically in agarose gels and densitometric
analysis was performed using Bio-Rad Quantity One software. E2 and E6 sequences of
HPV-16 were detected in 91% of the women. The free episomal viral genome was not
detected in the cervical carcinoma group. Twenty six percent of the samples obtained from
this group harboured the integrated form, whereas the remaining samples possessed a
mixture, i.e. episomal and integrated forms of viral DNA. The free episomal form dominated
in women with LSIL and HSIL. In 6 cases the episomal and integrated forms were detected
simultaneously. HPV-16 integration occurred in a subset of LSILs and HSILs, not only in the
cervical cancer patients and correlated with progression of cytological changes. The
assessment of the status of HPV-16 may be the molecular factor preceding the morphological
features leading to malignancy.
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Cervical cancer is one of the most frequent fe-
male malignant tumours and more than 500 000
new cases are reported each year all over the
world. The etiological association between human
papillomaviruses (HPV) and cervical cancer is
now well established. Among 100 types of HPV
discovered to date, about 30 are involved in ano-
genital infections. Epidemiological and biochemi-
cal data support the division of HPVs into two
groups: high-risk, such as HPV-16, 18, 31, 33, 35,
39, 45, 51, 52, 56, 58, 59, 68, 73 and 82, capable of
causing a progression to cancer of the uterine cer-
vix, and low-risk, such as HPV 6, 11, 40, 42, 43,
44, 54, 61, 70, 72, and 81, rarely, if ever, leading to
cancer (ZUR HAUSEN 2000; MUNOZ et al. 2003;
BOSCH et al. 2002). HPV-16 is the most exten-
sively studied HPV type and serves as an impor-
tant model for studying viral carcinogenesis (ZUR
HAUSEN 2002). The E6 and E7 genes of high-risk
HPV are known to play an important role in cervi-
cal carcinogenesis because they are highly ex-
pressed in cervical carcinoma cells and they have
the ability to transform and immortalize primary
keratinocytes (WOODWORTH et al. 1989; MUNGER
et al. 1989). In the process of inactivation of
tumour-suppressor gene products, the E6 proteins
lead to the degradation of the p53 protein, and the
binding complex of E7 and pRB proteins disturb
the normal cell cycle and maintain abnormal cellu-
lar proliferation (SCHEFFNER et al.1990; HECK et
al. 1992).
During a common infection and in most prema-
lignant lesions, HPV is in an episomal state. How-
ever, most cervical carcinomas and derived cell
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lines maintain the HPV genome in an integrated
form or in both integrated and episomal forms.
Thus, integration into the chromosomes of the host
cell has been proposed as an activation mechanism
for progression from preinvasive lesions to cervi-
cal cancer. The genome integration of HPV usu-
ally disrupts or deletes E2 gene open reading
frames, or rarely E1 open reading frames, which
results in the loss of expression of the correspond-
ing gene products. Disruption of these genes also
leads to overexpression of the E6 and E7 oncopro-
teins, since the E2 gene products can repress ac-
tivities from the HPV promoters that direct the
expression of the E6 and E7 genes (ZUR HAUSEN
2002). The disruption of the E2 gene will cause the
absence of the E2 gene sequences in the PCR prod-
uct following integration.
Our study was undertaken to determine the
physical status of HPV-16 by analyzing the ratios
of E2 and E6 genes by multiplex PCR and to assess
the viral integration of HPV-16 in cervical cell
DNA from women with different grades of squa-
mous intraepithelial lesions in comparison to cer-
vical cancer patients.
Material and Methods
Sixty five HPV-16 positive cervical smears were
classified by cytological examinations as low
grade squamous intraepithelial lesions – LSIL (n=30),
high grade squamous intraepithelial lesions – HSIL
(n=12) and cervical carcinoma (n=23). Material
was sampled from 20-75 year old women (average
age for LSIL woman 36 years, for HSIL – 43 years
and for cervical carcinoma 48 years). Specimens
were collected in Digene Specimen Transport Me-
dium (Digene Diagnostic, USA) and stored frozen
at –70oC until processed.
DNA isolation
DNA was isolated using the Genomic DNA Prep
Plus kit (A&A Biotechnology, Poland). Cell samples
were lyzed in buffer with proteinase K (20mg/ml)
and chaotropic salts. Addition of ethanol caused DNA
to bind when the lysate was spun through a silica
membrane in a microcentrifuge tube. Following
washing to remove contaminants, DNA was eluted
in 10mM TRIS-HCl pH 8,5 (preheat to 75°C).
PCR
HPV-16 detection was performed using the
SPF10 primers in order to amplify a 65 bp frag-
ment from the L1 region of the HPV genome and
was followed by reverse hybridization (INNO-
LiPA, Innogenetics, Belgium).
Multiplex PCR
The E2 and E6 genes of HPV-16 were detected
by multiplex PCR using 2 pairs of primers synthe-
sized according toYOSHINOUCHI (YOSHINOUCHI
et al. 1999).
The primers for each sequence were:
5’-CTTGGGCACCGAAGAAACAC-3’,
5’-TTGGTCACGTTGCCATTCAC-3’ for the E2
gene and
5’-AAGGGCGTAACCGAAATCGGT-3’,
5’-CATATACCTCACGTCGCAG-3’ for the E6
gene
The amplicon sizes were 352 bp and 208 bp for
the E2 and E6 sequences, respectively. PCR was
performed in a final reaction volume of 25 Fl, con-
taining PCR buffer (50 mM KCl, 10 mM Tris-HCl,
pH 8.3), 1.5 mM MgCl2, 200 FM dNTPs, 0.4 FM
of each primers, 2.5 U Ampli Taq Gold DNA po-
lymerase (Perkin Elmer, USA) and template DNA
(1Fg). The amount of isolated DNA was estimated
spectrophotometrically. DNA extracted from cer-
vical carcinoma cell line CaSki was used as posi-
tive control. The PCR conditions were as follows:
initial cycle – 95°C for 5 min, 52°C for 1 min, 72°C
for 1 min; the following 30 cycles: 95°C for 1 min,
52°C for 1 min, 72°C for 1 min; the final cycle –
95°C for 1 min, 52°C for 1 min, 72°C for 8 min.
The PCR products were separated electropho-
retically in 2% agarose gels. Transilluminated gel
images were digitalized and analyzed by the Gel
Doc 2000 documentation system (Bio-Rad, USA).
Values corresponding to the intensity and density
of the gel bands of different PCR products were
obtained with the help of Quantity One 4.0 soft-
ware (Bio-Rad, USA). The ratio of E2 to E6 copy
numbers was calculated to determine the physical
status of the HPV-16 viral gene. HPV-16 in pure
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Table 1
Correlation between physical status of
HPV-16 DNA and cytological diagnoses
Cytology
Physical status of HPV-16 DNA
Episomal
E2/E6$1
Episomal
and integrated
1>E2/E6>0
Integrated
E2/E6=0
LSIL
n=30
28 2 0
HSIL
n=12
8 4 0
Ca*
n=23
0 17 6
Ca* – cervical carcinoma
episomal form was expected to have equivalent
copy numbers of E2 and E6 genes (E2/E6 ratio> 1
or =1), whereas preferential disruption of E2 upon
viral integration should result in less E2 gene cop-
ies than E6. This means that an E2/E6 ratio of less
than 1 would indicate the presence of both inte-
grated and episomal forms, while a ratio of 0
would indicate the presence of integrated form
only.
Results and Discussion
A total of 65 samples were examined in which
HPV-16 was previously confirmed by the SPF-10
primer set and reverse hybridization. Several tech-
niques have been described for the elucidation of
HPV-16 status in infected cells, such as Southern
blot, real-time PCR and two dimensional gel elec-
trophoresis (PARK et al. 1997; NAGAO et al. 2002;
HUDELIST et al. 2004). In this study we used multi-
plex PCR with primers specific for E2 and E6
genes and analyzed the quantitative ratio of PCR
products.
HPV-16 E6 was found in all specimens. The E2
sequence of HPV-16 was detected in 59 (91%)
samples, suggesting that in the remaining negative
samples the virus may have been in integrated
form only. The physical status of HPV-16 in sam-
ples with different cytological results are shown in
Table 1. In women with LSIL and HSIL, the episo-
mal form dominated (93% and 67%, respectively,
with E2/E6 ratio>1 or =1). In 6 cases the episomal
and integrated forms of HPV-16 were detected si-
multaneously. In material obtained from patients
with cervical cancer the E2 region was amplified
in 17 (74%) of cases. In this group 26% of patients
exclusively harboured the integrated form (E2/E6
ratio = 0). In women with cervical carcinoma no
free episomal HPV-16 was found but only mixed
(1>E2/E6 ratio>0) or integrated forms of the viral
genome. The examinations showed a tendency of
increasing frequency of HPV-16 integration with
progression to malignancy. We confirmed also
that HPV-16 integration occurred in a subset of
LSILs and HSILs, not only in the cervical cancer
specimens. This may suggest that viral integration
may occur earlier than the onset of morphological
changes, which could indicate a high grade lesion.
The assessment of HPV-16 status may be a helpful
complementary tool for cytological study in cervi-
cal screening to identify women at risk for devel-
oping high grade squamous intraepithelial lesions
or carcinoma.
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